Use of composite end points to measure clinical events
JAMA
.
2003 Sep 17;290(11):1456-7; author reply 1457.
doi: 10.1001/jama.290.11.1456-c.
Authors
Frank van Leth
,
Joep M A Lange
PMID:
13129983
DOI:
10.1001/jama.290.11.1456-c
No abstract available
Publication types
Comment
Letter
MeSH terms
Anti-HIV Agents / therapeutic use
Clinical Trials as Topic*
HIV Infections / drug therapy
Humans
Treatment Failure*
Substances
Anti-HIV Agents